Federal Tax Policy and Year-End M&A Activity

With the all-but-guaranteed tax increases in 2022 that are just around the corner, many corporate transactions that were already in the pipeline are accelerating to close before year-end. There are a range of potential tax implications that give deal makers reason to push through to an early deadline.

2022-01-20T10:39:13-05:00December 13, 2021|Categories: Mergers & Acquisitions, Transaction Advisory|Tags: , |

Valuing Your Business

A business valuation helps to determine the fair market value of a company and may be needed for a variety of reasons such as buying or selling a business, transferring equity, developing an estate plan or purchasing insurance. In this video, you'll learn why you might need a valuation and the common methodologies used to determine value.

2022-01-03T14:35:40-05:00November 30, 2021|Categories: Business Valuation, Transaction Advisory|Tags: |

Vital Signs: The State of the Markets

Vital Signs: The State of the Markets is a quarterly overview of key trends and market conditions in the capital markets in which PBMares is active and engaged. Download our key takeaways for the 4th Quarter of 2020.

2022-01-20T16:56:30-05:00January 26, 2021|Categories: Business Advisory, Business Valuation, Transaction Advisory, Vital Signs|Tags: , |

M&A Due Diligence in the Era of Covid-19: PPP Loans Considerations

The Covid-19 pandemic has disrupted most economic sectors worldwide prompting governments to enact emergency stimulus measures to help businesses navigate the situation.

2021-01-26T11:30:21-05:00December 9, 2020|Categories: PBMares COVID-19 Insights, Transaction Advisory|Tags: , , |

It’s Déjà Vu All Over Again for Physician Practice Acquisitions

What goes around comes around. In a trend mirroring that which occurred in the 1990s, physician practices are selling out to hospitals and private equity firms in increasing numbers.

2022-01-20T17:06:20-05:00September 24, 2020|Categories: Healthcare, Transaction Advisory|Tags: , |

Keys to Addressing the EBITDA Impact of COVID-19

(authored by RSM US LLP) COVID-19 has significantly reduced M&A activity during the first and second quarters of 2020 and it is unclear when deal activity will get back to pre-pandemic rates.

2020-07-16T17:49:59-04:00July 16, 2020|Categories: Business Advisory, Consulting, Transaction Advisory|

Due Diligence Should Be More Than Numbers

Whether it is to gain access to new technologies or increase resources and market presence, more companies, large and small are considering a merger or acquisition. 

Go to Top

As Internet Explorer will discontinue browser security updates by August of 2021, this site is best viewed using Google Chrome, Safari or Microsoft Edge.

Click to Continue